Should I add a daily oral second‑generation antihistamine and montelukast to my maintenance regimen for asthma and allergic rhinitis alongside my inhaled medications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Should You Add Oral Antihistamine and Montelukast to Your Asthma and Rhinitis Maintenance Regimen?

Yes, you should add a daily oral second-generation antihistamine for your allergic rhinitis symptoms alongside your inhalers, but montelukast should only be added if you cannot tolerate or refuse intranasal corticosteroids, or if your asthma remains inadequately controlled on inhaled corticosteroids alone. 1, 2

Oral Antihistamines for Rhinitis

  • Oral antihistamines are appropriate and effective for treating your allergic rhinitis symptoms when used alongside your asthma inhalers, as they target rhinitis specifically and do not interfere with asthma management. 1

  • The ARIA guidelines explicitly state that oral H1-antihistamines should not be used to treat asthma symptoms themselves, but they remain fully appropriate for managing rhinitis in patients who have both conditions. 1

  • Second-generation antihistamines (like cetirizine, levocetirizine, or loratadine) are preferred because they have lower sedation risk compared to first-generation agents. 3

Montelukast: A More Nuanced Decision

When Montelukast Should NOT Be Your First Choice

  • Inhaled corticosteroids are strongly preferred over montelukast as the primary controller medication for asthma, based on moderate-quality evidence showing superior efficacy. 1

  • For allergic rhinitis alone, intranasal corticosteroids are superior to montelukast and should be your first-line treatment. 4, 2, 3

  • Montelukast is less effective than both intranasal corticosteroids for rhinitis control and inhaled corticosteroids for asthma control when used as monotherapy. 2, 5, 6, 7

When Montelukast SHOULD Be Added

  • If you cannot tolerate or refuse to use inhaled corticosteroids (or if you are "steroid-phobic"), montelukast becomes a reasonable alternative controller medication for mild persistent asthma. 1, 2

  • If your asthma remains inadequately controlled on inhaled corticosteroids alone, adding montelukast is a valid option, though long-acting beta-agonists (LABAs) are generally preferred as add-on therapy in patients ≥12 years. 1, 4, 3

  • Montelukast offers the unique advantage of treating both your upper and lower airway disease simultaneously, which can be particularly valuable when you have both asthma and allergic rhinitis. 2, 3, 8

Combination Therapy: Antihistamine Plus Montelukast

  • Combining an oral antihistamine with montelukast provides better symptom control than either medication alone for allergic rhinitis, and some studies suggest this combination may approach the efficacy of intranasal corticosteroids. 2, 5, 6

  • However, this combination is still generally less effective than intranasal corticosteroids for rhinitis control and should be reserved for patients who fail or cannot tolerate nasal steroids. 2, 3

  • In patients with both asthma and allergic rhinitis, the combination of antihistamine plus montelukast produces inhibition of allergen-induced airway obstruction and may improve both conditions. 3

Critical Safety Warning for Montelukast

  • The FDA issued a black box warning regarding serious neuropsychiatric events with montelukast, including suicidal thoughts, depression, anxiety, sleep disturbances, and behavioral changes. 4

  • Before starting montelukast, you must be explicitly counseled about these neuropsychiatric risks, and monitoring for unusual behavioral or mood changes is required, particularly in the first weeks of therapy. 4

  • If you experience any mood changes, behavioral changes, or concerning psychological symptoms while taking montelukast, discontinue it immediately and contact your physician. 3

Practical Algorithm for Your Situation

Step 1: Optimize your inhaled asthma medications first

  • Ensure you are on an appropriate dose of inhaled corticosteroids (with or without LABA) as your primary asthma controller. 1

Step 2: Add intranasal corticosteroids for rhinitis

  • This is the most effective treatment for allergic rhinitis and should be your first add-on for nasal symptoms. 4, 2, 3

Step 3: Add oral antihistamine if rhinitis symptoms persist

  • A second-generation antihistamine can be safely added to your regimen for additional rhinitis control. 2, 3

Step 4: Consider montelukast only if:

  • You cannot tolerate or refuse intranasal/inhaled corticosteroids, OR
  • Your asthma remains uncontrolled despite adequate inhaled corticosteroid therapy, OR
  • You prefer a single oral medication to treat both conditions simultaneously (understanding it is less effective than optimal inhaled/intranasal therapy). 1, 2

Common Pitfalls to Avoid

  • Do not use montelukast as your primary asthma controller if you can tolerate inhaled corticosteroids – this violates guideline recommendations and provides suboptimal asthma control. 1, 4

  • Do not expect montelukast to work immediately – its onset of action occurs by the second day of daily treatment, unlike antihistamines which work quickly. 4, 2

  • Do not use montelukast for acute asthma symptoms or rescue therapy – you must have a short-acting beta-agonist available for acute symptoms. 4

  • Do not assume adding an antihistamine to intranasal corticosteroids provides additional benefit as initial therapy – evidence does not support this approach at treatment initiation. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Montelukast Therapy for Allergic Rhinitis and Asthma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Upper Airway Cough Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Montelukast Use in Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Montelukast in the management of allergic rhinitis.

Therapeutics and clinical risk management, 2007

Research

Montelukast in allergic rhinitis: a systematic review and meta-analysis.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2006

Related Questions

Should montelukast (Singulair) be discontinued before surgery in a patient with asthma or allergic rhinitis?
Is there a link between Montelukast (Singulair) and suicidal behavior?
What is the likely diagnosis and appropriate management for an 11‑month‑old infant (weight 40.5 kg) with an 18‑day dry cough worsening at noon that progressed to a yellow productive cough after ocean swimming, who has been on montelukast and salbutamol (Asmatrol) syrup, shows allergic rhinitis signs (boggy tonsils, swollen non‑erythematous nostrils), normal vital signs, and a sibling with a similar presentation?
What is the recommended dosage and treatment plan for Monteleukast (Singulair) in patients with asthma or seasonal allergic rhinitis?
Can missing doses of montelukast (Singulair) cause hives?
Can nicotinamide mononucleotide (NMN) supplementation cause headaches?
What postoperative after‑care is recommended for a patient after an anal gland fistulectomy?
What is the recommended treatment approach for diabetic retinopathy, including systemic control and stage‑specific ocular therapies?
What is the recommended first‑line therapy for acute herpes zoster, including antiviral selection, dosing, and pain management, for immunocompetent adults and for severely immunocompromised patients?
How should I dose long‑acting injectable aripiprazole (Abilify Maintena) for an adult patient already stabilized on oral aripiprazole 10–30 mg daily?
What are the indications, dosing regimen, contraindications, side effects, and alternative treatments for constipation when using Senna‑Dul (senna and bisacodyl)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.